Logo image of GAM.PA

GAUMONT SA (GAM.PA) Stock Fundamental Analysis

Europe - EPA:GAM - FR0000034894 - Common Stock

79.5 EUR
-0.5 (-0.62%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

3

GAM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 46 industry peers in the Entertainment industry. The financial health of GAM is average, but there are quite some concerns on its profitability. GAM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year GAM has reported negative net income.
GAM had a positive operating cash flow in the past year.
GAM had negative earnings in 4 of the past 5 years.
Each year in the past 5 years GAM had a positive operating cash flow.
GAM.PA Yearly Net Income VS EBIT VS OCF VS FCFGAM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of GAM (-2.04%) is comparable to the rest of the industry.
GAM's Return On Equity of -4.16% is in line compared to the rest of the industry. GAM outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -2.04%
ROE -4.16%
ROIC N/A
ROA(3y)-1.86%
ROA(5y)-1.74%
ROE(3y)-4.1%
ROE(5y)-3.94%
ROIC(3y)N/A
ROIC(5y)N/A
GAM.PA Yearly ROA, ROE, ROICGAM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

GAM has a better Gross Margin (92.05%) than 84.78% of its industry peers.
In the last couple of years the Gross Margin of GAM has remained more or less at the same level.
GAM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.33%
GAM.PA Yearly Profit, Operating, Gross MarginsGAM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

6

2. Health

2.1 Basic Checks

GAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GAM remains at a similar level compared to 1 year ago.
The number of shares outstanding for GAM remains at a similar level compared to 5 years ago.
Compared to 1 year ago, GAM has a worse debt to assets ratio.
GAM.PA Yearly Shares OutstandingGAM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
GAM.PA Yearly Total Debt VS Total AssetsGAM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

GAM has an Altman-Z score of 1.68. This is a bad value and indicates that GAM is not financially healthy and even has some risk of bankruptcy.
GAM's Altman-Z score of 1.68 is fine compared to the rest of the industry. GAM outperforms 60.87% of its industry peers.
The Debt to FCF ratio of GAM is 0.72, which is an excellent value as it means it would take GAM, only 0.72 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GAM (0.72) is better than 95.65% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that GAM is not too dependend on debt financing.
GAM's Debt to Equity ratio of 0.05 is amongst the best of the industry. GAM outperforms 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.72
Altman-Z 1.68
ROIC/WACCN/A
WACC7.69%
GAM.PA Yearly LT Debt VS Equity VS FCFGAM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

GAM has a Current Ratio of 1.14. This is a normal value and indicates that GAM is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.14, GAM is doing good in the industry, outperforming 67.39% of the companies in the same industry.
A Quick Ratio of 1.14 indicates that GAM should not have too much problems paying its short term obligations.
The Quick ratio of GAM (1.14) is better than 67.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
GAM.PA Yearly Current Assets VS Current LiabilitesGAM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for GAM have decreased strongly by -106.90% in the last year.
The Revenue for GAM has decreased by -12.85% in the past year. This is quite bad
Measured over the past years, GAM shows a decrease in Revenue. The Revenue has been decreasing by -6.68% on average per year.
EPS 1Y (TTM)-106.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.24%
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y-17.38%
Revenue growth 5Y-6.68%
Sales Q2Q%-31.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GAM.PA Yearly Revenue VS EstimatesGAM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

GAM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GAM.PA Price Earnings VS Forward Price EarningsGAM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GAM is valued cheaper than 80.43% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GAM is valued a bit cheaper than 78.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.45
EV/EBITDA 3.5
GAM.PA Per share dataGAM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GAM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GAUMONT SA

EPA:GAM (9/12/2025, 7:00:00 PM)

79.5

-0.5 (-0.62%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)09-10 2025-09-10
Earnings (Next)03-04 2026-03-04
Inst Owners4.95%
Inst Owner ChangeN/A
Ins Owners89.79%
Ins Owner ChangeN/A
Market Cap248.04M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.65
P/FCF 15.45
P/OCF 2.54
P/B 1.35
P/tB 3.93
EV/EBITDA 3.5
EPS(TTM)-2.45
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)5.15
FCFY6.47%
OCF(TTM)31.25
OCFY39.3%
SpS48.11
BVpS59.09
TBVpS20.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.04%
ROE -4.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 92.05%
FCFM 10.7%
ROA(3y)-1.86%
ROA(5y)-1.74%
ROE(3y)-4.1%
ROE(5y)-3.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.33%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.72
Debt/EBITDA 0.2
Cap/Depr 143.29%
Cap/Sales 54.25%
Interest Coverage N/A
Cash Conversion 206.06%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 1.68
F-Score4
WACC7.69%
ROIC/WACCN/A
Cap/Depr(3y)93.45%
Cap/Depr(5y)100.19%
Cap/Sales(3y)40.27%
Cap/Sales(5y)48.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.85%
Revenue growth 3Y-17.38%
Revenue growth 5Y-6.68%
Sales Q2Q%-31.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-349.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.51%
FCF growth 3Y-9.67%
FCF growth 5YN/A
OCF growth 1Y8.54%
OCF growth 3Y-11.79%
OCF growth 5Y-4.74%